Leef Brands (LEEEF) EBT Margin (2025 - 2026)
Leef Brands (LEEEF) posted EBT Margin of 5.85% for Q1 2026, down 44.31% sequentially from 10.5% in Q1 2025, and down 465.0% YoY from 1.6% in Q1 2025.
Leef Brands (LEEEF) EBT Margin (2025 - 2026) Analysis & Trends
Leef Brands has reported EBT Margin for 2 years, with the latest figure at 5.85% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Leef Brands | 59.45 Mn | 54.50 Mn | 2.41 Mn | -8.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.67% |
| Mar 31, 2026 | 5.85% |
| Mar 31, 2025 | 10.50% |